Lloyd A. Rowland
2020
In 2020, Lloyd A. Rowland earned a total compensation of $953.4K as Senior Vice President, General Counsel, Chief Compliance Officer and Secretary at CytomX Therapeutics, a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $161,460 |
|---|---|
| Option Awards | $378,570 |
| Salary | $403,650 |
| Other | $9,713 |
| Total | $953,393 |
Rowland received $403.7K in salary, accounting for 42% of the total pay in 2020.
Rowland also received $161.5K in non-equity incentive plan, $378.6K in option awards and $9.7K in other compensation.
Rankings
In 2020, Lloyd A. Rowland's compensation ranked 8,829th out of 13,090 executives tracked by ExecPay. In other words, Rowland earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,829 out of 13,090 | 33rd |
Division Manufacturing | 3,765 out of 5,621 | 33rd |
Major group Chemicals And Allied Products | 1,520 out of 2,254 | 33rd |
Industry group Drugs | 1,324 out of 1,954 | 32nd |
Industry Pharmaceutical Preparations | 979 out of 1,459 | 33rd |
Source: SEC filing on April 27, 2022.
Rowland's colleagues
We found four more compensation records of executives who worked with Lloyd A. Rowland at CytomX Therapeutics in 2020.